Usefulness of fungal biomarkers for diagnosis and therapy monitoring in patients with candidemia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005135

Enrollment

130

Registered

2013-07-24

Start date

2013-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B37.7

Interventions

Group 1: Sera of patients with culture-proven Candida bloodstream infection are tested with the following assays: Fungitell-Test Platelia Candida Ag Plus-Test Platelia Candida Ak Plus-Test

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Culture-proven candidemia

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Sensitivity/Specificity of the antigen assays	—

Secondary

Measure	Time frame
Earliest time point of positive index test	—

Countries

Germany

Contacts

Public ContactJürgen Held

Uniklinik Erlangen, Mikrobiologisches Institut

juergen.held@uk-erlangen.de09131-8546903

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026